Evidence map›Paper›PMID 37726050›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2024

Kidney Transplant Clinicians' Perceptions of Palliative Care for Patients With Failing Allografts in the US: A Mixed Methods Study.

Naoka Murakami, Amanda J Reich, Katherine He, Samantha L Gelfand, Richard E Leiter, Kate Sciacca, Joel T Adler, Emily Lu, Song C Ong, Beatrice P Concepcion and 8 more

Open access · greenAbstract read
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 13 institutions in 2 countries.

Naoka MurakamiDivision of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Amanda J ReichCenter for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.
Katherine HeDepartment of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
Samantha L GelfandDivision of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts.
Richard E LeiterDepartment of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts.
Kate SciaccaDepartment of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts.
Joel T AdlerDepartment of Surgery, Dell Medical School, University of Texas at Austin, Austin, Texas.
Emily LuDivision of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York.
Song C OngDivision of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama.
Beatrice P ConcepcionDivision of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee.
Neeraj SinghWillis Knighton Health System, Shreveport, Louisiana.
Haris MuradDepartment of Medicine, Aga Khan University, Karachi, Pakistan.
Prince AnandMedical University of South Carolina, Greenville, South Carolina.
Sarah J RamerJames J Peters VA Medical Center, Bronx, New York.
Darshana M DadhaniaWeill Cornell Medicine-New York Presbyterian Hospital, New York, New York.
Krista L LentineSaint Louis University Transplant Center, SSM-Saint Louis University Hospital, St Louis, Missouri.
Joshua R LakinDepartment of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: Joshua_Lakin@dfci.harvard.edu.
Tarek AlhamadDivision of Nephrology, Washington University in St. Louis, St. Louis, Missouri. Electronic address: talhamad@wustl.edu.
Brigham and Women's Hospital · USDana-Farber Cancer Institute · USAga Khan University · PKIcahn School of Medicine at Mount Sinai · USJames J. Peters VA Medical Center · USMedical University of South Carolina · USNewYork–Presbyterian Hospital · USSaint Louis University Hospital · USThe University of Texas at Austin · USUniversity of Alabama at Birmingham · USVanderbilt University Medical Center · USWashington University in St. Louis · USWillis-Knighton Cancer Center · US

Funding

Protection of kidney from autoimmunity by modulating co-stimlatory signalingK08DK120868 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI MURAKAMI, NAOKA · 2019 to 2023
$886k
NIDDK NIH HHS K08 DK120868
6 · The paper itself

Abstract

RATIONALE &

objectiveKidney transplant patients with failing allografts have a physical and psychological symptom burden as well as high morbidity and mortality. Palliative care is underutilized in this vulnerable population. We described kidney transplant clinicians' perceptions of palliative care to delineate their perceived barriers to and facilitators of providing palliative care to this population. STUDY

designNational explanatory sequential mixed methods study including an online survey and semistructured interviews. SETTING &

participantsKidney transplant clinicians in the United States surveyed and interviewed from October 2021 to March 2022. ANALYTICAL APPROACH: Descriptive summary of survey responses, thematic analysis of qualitative interviews, and mixed methods integration of data.

resultsA total of 149 clinicians completed the survey, and 19 completed the subsequent interviews. Over 90% of respondents agreed that palliative care can be helpful for patients with a failing kidney allograft. However, 46% of respondents disagreed that all patients with failing allografts benefit from palliative care, and two-thirds thought that patients would not want serious illness conversations. More than 90% of clinicians expressed concern that transplant patients and caregivers would feel scared or anxious if offered palliative care. The interviews identified three main themes: (1) transplant clinicians' unique sense of personal and professional responsibility was a barrier to palliative care engagement, (2) clinicians' uncertainty regarding the timing of palliative care collaboration would lead to delayed referral, and (3) clinicians felt challenged by factors related to patients' cultural backgrounds and identities, such as language differences. Many comments reflected an unfamiliarity with the broad scope of palliative care beyond end-of-life care. LIMITATIONS: Potential selection bias.

conclusionsOur study suggests that multiple barriers related to patients, clinicians, health systems, and health policies may pose challenges to the delivery of palliative care for patients with failing kidney transplants. This study illustrates the urgent need for ongoing efforts to optimize palliative care delivery models dedicated to kidney transplant patients, their families, and the clinicians who serve them. PLAIN-LANGUAGE SUMMARY: Kidney transplant patients experience physical and psychological suffering in the context of their illnesses that may be amenable to palliative care. However, palliative care is often underutilized in this population. In this mixed-methods study, we surveyed 149 clinicians across the United States, and 19 of them completed semistructured interviews. Our study results demonstrate that several patient, clinician, system, and policy factors need to be addressed to improve palliative care delivery to this vulnerable population.

Indexed as

Hospice CareKidney TransplantationTerminal CareAllograftsHumansPalliative CareUnited StatesAllograft failurekidney transplantmixed methods studypalliative care

Identifiers

PMID37726050
PMCPMC11360225
OpenAlexW4386811542

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.